Investments
90Portfolio Exits
46
Want to inform investors similar to Surveyor Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Surveyor Capital News
Oct 17, 2022
Nasdaq-listed VectivBio Holding, a clinical-stage biopharmaceutical company, has priced an underwritten offering of 16,700,000 ordinary shares at US$7.50 per share, raising US$125m in gross proceeds. Investors agreeing to underwrite the offer include Cowen Healthcare Investments, Driehaus Capital Management, Eventide Asset Management, Forbion’s Growth Opportunities Fund, Frazier Life Sciences, Marshall Wace, OrbiMed, Surveyor Capital, TCG X, […]
Surveyor Capital Investments
90 Investments
Surveyor Capital has made 90 investments. Their latest investment was in Entact Bio as part of their Series A on December 12, 2022.
Surveyor Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
12/6/2022 | Series A | Entact Bio | $81M | Yes | 11 | |
9/13/2022 | Series C | ACELYRIN | $300M | No | 15 | |
5/17/2022 | Series B | Remix Therapeutics | $70M | Yes | 5 | |
3/30/2022 | Series C | |||||
2/23/2022 | Series B |
Date | 12/6/2022 | 9/13/2022 | 5/17/2022 | 3/30/2022 | 2/23/2022 |
|---|---|---|---|---|---|
Round | Series A | Series C | Series B | Series C | Series B |
Company | Entact Bio | ACELYRIN | Remix Therapeutics | ||
Amount | $81M | $300M | $70M | ||
New? | Yes | No | Yes | ||
Co-Investors | |||||
Sources | 11 | 15 | 5 |
Surveyor Capital Portfolio Exits
46 Portfolio Exits
Surveyor Capital has 46 portfolio exits. Their latest portfolio exit was Enliven Therapeutics on February 23, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/23/2023 | Reverse Merger | 4 | |||
2/3/2023 | IPO | Public | 23 | ||
1/5/2023 | Acquired | 8 | |||
Date | 2/23/2023 | 2/3/2023 | 1/5/2023 | ||
|---|---|---|---|---|---|
Exit | Reverse Merger | IPO | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 4 | 23 | 8 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.